CONMED CORPORATION Cash and Cash Equivalents
CONMED CORPORATION (CNMD) had Cash and Cash Equivalents of $25.86 million as of 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2020-02-24
- 2019-12-31: Cash and Cash Equivalents, at Carrying Value $25.86M.
- 2019-09-30: Cash and Cash Equivalents, at Carrying Value $30.07M.
- 2019-06-30: Cash and Cash Equivalents, at Carrying Value $22.55M.
- 2019-03-31: Cash and Cash Equivalents, at Carrying Value $23.41M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2019-12-31 | $25.86M 10-K · filed 2020-02-24 |
| 2019-09-30 | $30.07M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $22.55M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $23.41M 10-Q · filed 2019-04-26 |
| 2018-12-31 | $17.51M 10-K · filed 2020-02-24 |
| 2018-09-30 | $29.69M 10-Q · filed 2019-10-31 |
| 2018-06-30 | $23.40M 10-Q · filed 2019-08-01 |
| 2018-03-31 | $21.13M 10-Q · filed 2019-04-26 |
| 2017-12-31 | $32.62M 10-K · filed 2020-02-24 |
| 2017-09-30 | $44.03M 10-Q · filed 2018-11-02 |
| 2017-06-30 | $40.14M 10-Q · filed 2018-08-02 |
| 2017-03-31 | $34.66M 10-Q · filed 2018-04-26 |
| 2016-12-31 | $27.43M 10-K · filed 2020-02-24 |
| 2016-09-30 | $26.95M 10-Q · filed 2017-11-02 |
| 2016-06-30 | $23.30M 10-Q · filed 2017-07-27 |
| 2016-03-31 | $19.89M 10-Q · filed 2017-04-27 |
| 2015-12-31 | $72.50M 10-K · filed 2019-02-25 |
| 2015-09-30 | $65.33M 10-Q · filed 2016-10-28 |
| 2015-06-30 | $62.22M 10-Q · filed 2016-07-28 |
| 2015-03-31 | $65.73M 10-Q · filed 2016-05-02 |
| 2014-12-31 | $66.33M 10-K · filed 2018-02-26 |
| 2014-09-30 | $64.61M 10-Q · filed 2015-10-23 |
| 2014-06-30 | $60.41M 10-Q · filed 2015-07-27 |
| 2014-03-31 | $56.32M 10-Q · filed 2015-04-24 |
| 2013-12-31 | $54.44M 10-K · filed 2017-02-27 |
| 2013-09-30 | $49.83M 10-Q · filed 2014-10-24 |
| 2013-06-30 | $38.12M 10-Q · filed 2014-07-25 |
| 2013-03-31 | $32.36M 10-Q · filed 2014-04-25 |
| 2012-12-31 | $23.72M 10-K · filed 2016-02-23 |
| 2012-09-30 | $19.82M 10-Q · filed 2013-10-28 |
| 2012-06-30 | $16.25M 10-Q · filed 2013-07-29 |
| 2012-03-31 | $19.45M 10-Q · filed 2013-04-29 |
| 2011-12-31 | $26.05M 10-K · filed 2015-02-23 |
| 2011-09-30 | $39.88M 10-Q · filed 2012-10-29 |
| 2011-06-30 | $24.33M 10-Q · filed 2012-07-30 |
| 2011-03-31 | $17.94M 10-Q · filed 2012-05-01 |
| 2010-12-31 | $12.42M 10-K · filed 2014-02-24 |
| 2010-09-30 | $16.52M 10-Q · filed 2011-11-01 |
| 2010-06-30 | $8.49M 10-Q · filed 2011-08-09 |
| 2009-12-31 | $10.10M 10-K · filed 2013-02-25 |
| 2008-12-31 | $11.81M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |